Latest Amines Stories
EMERYVILLE, Calif., June 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), today announced that the United States Patent and Trademark Office (USPTO) issued US Patent No.
PORTLAND, Ore., June 4, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held U.S.
CHARLOTTE, N.C., June 3, 2014 /PRNewswire/ -- The Carolina Men's Clinic (http://thecarolinamensclinic.com/) was
- 7 total abstracts accepted for afatinib and other compounds from the company's oncology research program RIDGEFIELD, Conn., May 30, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced
Enough Maui County residents have signed a petition to potentially place on the November 2014 ballot a temporary moratorium on all GE cultivation practices, including open-field GMO and pesticide
GAINESVILLE, Va., May 22, 2014 /PRNewswire/ -- Gather your friends and family and enjoy the outdoors with a fun BBQ, but most importantly make it a day full of remembrance and family traditions.
Oncoprex Combined with Tarceva for Patients With and Without EGFR Mutations AUSTIN, Texas, May 20, 2014 /PRNewswire/ -- Genprex,
-- Results from two Phase III studies (LUX-Lung 3 and LUX-Lung 6) add to the body of evidence supporting the importance of first-line treatment with afatinib in patients whose tumors express the EGFR
SAN DIEGO, May 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
- Lead NMDA Receptor Modulator GLYX-13 Shows Robust and Sustained Antidepressant Effects with Repeat Dosing and Is Well-Tolerated in Subjects with Difficult-to-Treat Depression - EVANSTON,
- A poem in which the author retracts something said in an earlier poem.